The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …

Over the course of the COVID-19 pandemic, numerous studies have aimed to address the
challenges faced by patients with kidney disease and their caregivers. These studies …

Background Preliminary evidence suggests patients on hemodialysis have a blunted early
serological response to SARS-CoV-2 vaccination. Optimizing the vaccination strategy in this …

The coronavirus disease 2019 (COVID-19) pandemic is causing extreme stress to many
health systems and an evermounting death toll. Out of the darkness of the last 14 months …

Abstract Background Coronavirus disease 2019 (COVID-19) has exposed haemodialysis
(HD) patients and kidney transplant (KT) recipients to an unprecedented life-threatening …

Methods In partnership with a nonprofit dialysis provider that serves patients undergoing
dialysis in four states (California, Texas, Tennessee, and New Jersey), we evaluated the …

MATERIALS AND METHODS We proposed the COVID-19 vaccination—two injections 3
weeks apart of the BNT162b2 mRNA COVID-19 vaccine—to all our in-centre haemodialysis …

Background Patients undergoing in-centre haemodialysis (HD) are particularly exposed to
the dire consequences of COVID-19. The present systematic scoping review aims to identify …

Results During the first wave, incidence in dialysis patients was approximately proportional
to the general population. However, we showed a lower relative incidence for dialysis …

Abstract Coronavirus disease 2019 (COVD-19) emerged as a pandemic in December 2019.
Infection has spread quickly and renal transplant recipients receiving chronic …